Article
HIOPP-3: Interprofessional optimization of medication in nursing home residents – a cluster randomized controlled trial
Search Medline for
Authors
-
Regina Stolz
- Institute for General Practice and Interprofessional Care, University Hospital Tübingen
-
Hannah Haumann
- Institute for General Practice and Interprofessional Care, University Hospital Tübingen
-
Stefanie Joos
- Institute for General Practice and Interprofessional Care, University Hospital Tübingen
-
Ina-Merle Doyle
- Institute for General Practice, Hannover Medical School
-
Claudia Kirsch
- Institute for General Practice, Hannover Medical School
-
Petra Thürmann
- Clinical Pharmacology, University Witten/Herdecke
-
Simone Bernard
- Clinical Pharmacology, University Witten/Herdecke
-
Attila Altiner
- Institute of General Practice, University Medical Center Rostock
-
Anja Wollny
- Institute of General Practice, University Medical Center Rostock
-
Stefan Wilm
- Institute of General Practice, University Hospital Düsseldorf
-
Achim Mortsiefer
- Institute of General Practice, University Hospital Düsseldorf
-
Stefanie Kortekamp
- University of Applied Sciences, Osnabrück
-
Birgitt Wiese
- Institute for General Practice, Hannover Medical School
-
Nils Schneider
- Institute for General Practice, Hannover Medical School
-
Jutta Bleidorn
- Institute for General Practice, Hannover Medical School
-
Ulrike Junius-Walker
- Institute for General Practice, Hannover Medical School
-
Olaf Krause
- Institute for General Practice, Hannover Medical School
| Published: | April 30, 2018 |
|---|
Outline
Text
Background and Purpose: Polypharmacy and potentially inadequate medication (PIM) such as neuroleptics are common in elderly nursing home residents. A lack of collaboration between health care professionals (HCP) involved in the medication process - general practitioners (GP), pharmacists and nurses – can lead to inadequate polypharmacy and PIM. HIOPP-3 aims to improve 1. medication safety with focus on number of PIM and neuroleptics and 2. the medication process in nursing homes by the use of an interprofessional toolbox.
Methods: Multi-centre cluster randomized controlled trial.
Research Focus: Sample size planned:760 nursing home residents ≥ 65 years in 32 nursing homes at 4 regions. A tailored intervention is applied in every nursing home. Main aspects are 1. medication review by pharmacists, 2. interprofessional toolbox incl. workshops and information material for HCPs aiming to initiate a change management process in HCP teams focusing on the collaboration in the medication process. Data will be collected at baseline and after 6 months.
Primary endpoint is the number of PIM/neuroleptics, evaluated by multilevel logistical regression model. Secondary endpoints are e.g. hospitalization rates, length of hospital stays, falls, quality of life, health economic evaluation, analyzed by mixed regression models.
Methodological and Theoretical Focus: Randomized-controlled trial with qualitative and quantitative process evaluation to optimize medication safety in nursing home residents.
Results: HIOPP-3 is in the recruiting phase. The presentation will include the study protocol and first experiences with the intervention.
Conclusions: HIOPP-3 aims to improve inter-professional collaboration in the medication process and thereby medication safety in nursing home facilities.
